Vinay Puduvalli
Vinay Puduvalli
Professor and Director, Division of Neurooncology, The Ohio State University Wexner Medical Center, Columbus OH
Verified email at
Cited by
Cited by
Phase III study of enzastaurin compared with lomustine in the treatment of recurrent intracranial glioblastoma
W Wick, VK Puduvalli, MC Chamberlain, MJ Van Den Bent, AF Carpentier, ...
Journal of clinical oncology 28 (7), 1168, 2010
Phase I/II study of imatinib mesylate for recurrent malignant gliomas: North American Brain Tumor Consortium Study 99-08
PY Wen, WKA Yung, KR Lamborn, PL Dahia, Y Wang, B Peng, LE Abrey, ...
Clinical Cancer Research 12 (16), 4899-4907, 2006
Phase II trial of temozolomide plus the matrix metalloproteinase inhibitor, marimastat, in recurrent and progressive glioblastoma multiforme
MD Groves, VK Puduvalli, KR Hess, KA Jaeckle, P Peterson, ...
Journal of Clinical Oncology 20 (5), 1383-1388, 2002
Brain metastasis from prostate carcinoma: The M. D. Anderson Cancer Center experience
IW Tremont‐Lukats, G Bobustuc, GK Lagos, K Lolas, AP Kyritsis, ...
Cancer 98 (2), 363-368, 2003
Histone deacetylases mediate the silencing of miR-15a, miR-16, and miR-29b in chronic lymphocytic leukemia
D Sampath, C Liu, K Vasan, M Sulda, VK Puduvalli, WG Wierda, ...
Blood, The Journal of the American Society of Hematology 119 (5), 1162-1172, 2012
NCCN guidelines insights: central nervous system cancers, version 1.2017
LB Nabors, J Portnow, M Ammirati, J Baehring, H Brem, N Butowski, ...
Journal of the National Comprehensive Cancer Network 15 (11), 1331-1345, 2017
Safety and pharmacokinetic effects of TNP-470, an angiogenesis inhibitor, combined with paclitaxel in patients with solid tumors: evidence for activity in non–small-cell lung …
RS Herbst, TL Madden, HT Tran, GR Blumenschein Jr, CA Meyers, ...
Journal of clinical oncology 20 (22), 4440-4447, 2002
miR‐29b and miR‐125a regulate podoplanin and suppress invasion in glioblastoma
MA Cortez, MS Nicoloso, M Shimizu, S Rossi, G Gopisetty, JR Molina, ...
Genes, Chromosomes and Cancer 49 (11), 981-990, 2010
Apparent diffusion coefficient histogram analysis stratifies progression-free and overall survival in patients with recurrent GBM treated with bevacizumab: a multi-center study
WB Pope, XJ Qiao, HJ Kim, A Lai, P Nghiemphu, X Xue, BM Ellingson, ...
Journal of neuro-oncology 108 (3), 491-498, 2012
Proton beam craniospinal irradiation reduces acute toxicity for adults with medulloblastoma
AP Brown, CL Barney, DR Grosshans, MF McAleer, JF De Groot, ...
International Journal of Radiation Oncology* Biology* Physics 86 (2), 277-284, 2013
Phase II study of carboplatin and erlotinib (Tarceva, OSI-774) in patients with recurrent glioblastoma
JF De Groot, MR Gilbert, K Aldape, KR Hess, TA Hanna, S Ictech, ...
Journal of neuro-oncology 90 (1), 89-97, 2008
Inhibition of SOAT1 suppresses glioblastoma growth via blocking SREBP-1–mediated lipogenesis
F Geng, X Cheng, X Wu, JY Yoo, C Cheng, JY Guo, X Mo, P Ru, B Hurwitz, ...
Clinical Cancer Research 22 (21), 5337-5348, 2016
A multicenter phase II trial of intrathecal topotecan in patients with meningeal malignancies
MD Groves, MJ Glantz, MC Chamberlain, KE Baumgartner, CA Conrad, ...
Neuro-oncology 10 (2), 208-215, 2008
Specific activation of microRNA106b enables the p73 apoptotic response in chronic lymphocytic leukemia by targeting the ubiquitin ligase Itch for degradation
D Sampath, GA Calin, VK Puduvalli, G Gopisetty, C Taccioli, CG Liu, ...
Blood, The Journal of the American Society of Hematology 113 (16), 3744-3753, 2009
Biomarkers of disease: cerebrospinal fluid vascular endothelial growth factor (VEGF) and stromal cell derived factor (SDF)-1 levels in patients with neoplastic meningitis (NM …
MD Groves, KR Hess, VK Puduvalli, H Colman, CA Conrad, MR Gilbert, ...
Journal of neuro-oncology 94 (2), 229-234, 2009
A phase II trial of erlotinib (OSI-774) in patients (pts) with recurrent malignant gliomas (MG) not on EIAEDs
JJ Raizer, LE Abrey, P Wen, T Cloughesy, IA Robins, HA Fine, ...
Journal of Clinical Oncology 22 (14_suppl), 1502-1502, 2004
A North American brain tumor consortium (NABTC 99-04) phase II trial of temozolomide plus thalidomide for recurrent glioblastoma multiforme
MD Groves, VK Puduvalli, SM Chang, CA Conrad, MR Gilbert, ...
Journal of Neuro-oncology 81 (3), 271-277, 2007
Treatment of glioblastoma (GBM) with the addition of tumor-treating fields (TTF): a review
D Fabian, MP Guillermo Prieto Eibl, I Alnahhas, N Sebastian, P Giglio, ...
Cancers 11 (2), 174, 2019
Phase II trial of irinotecan and thalidomide in adults with recurrent glioblastoma multiforme
VK Puduvalli, P Giglio, MD Groves, KR Hess, MR Gilbert, S Mahankali, ...
Neuro-oncology 10 (2), 216-222, 2008
Anaplastic oligodendrogliomas: prognostic factors for tumor recurrence and survival
VK Puduvalli, M Hashmi, LD McAllister, VA Levin, KR Hess, M Prados, ...
Oncology 65 (3), 259-266, 2003
The system can't perform the operation now. Try again later.
Articles 1–20